Influence of ramipril on right ventricular hypertrophy induced by pulmonary artery stenosis in rats

Journal of Cardiovascular Pharmacology

Volumn 16, Issue 3, 1990, Pages 480-486

  Zierhut, W ^a,c   Zimmer, H G ^a   Gerdes, A M ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Preclinical Research   (Switzerland)

Author keywords

Angiotensin; Converting enzyme inhibition; Pulmonary artery stenosis; Right ventricular hypertrophy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SIZE; FEMALE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART WEIGHT; HEMODYNAMICS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULMONARY ARTERY STENOSIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; BICYCLO COMPOUNDS; BLOOD PRESSURE; CARDIOMEGALY; CONSTRICTION, PATHOLOGIC; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; HEMODYNAMICS; PULMONARY ARTERY; RAMIPRIL; RATS; RATS, INBRED STRAINS; RENIN-ANGIOTENSIN SYSTEM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025031674     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199009000-00019     Document Type: Article

References (36)

1. Dzau VJ, Ingelfinger JR, Pratt RE. Regulation of tissue renin and angiotensin gene expressions. J Cardiovasc Pharmacol 1986;8(suppl 10):S11-S16.
2. Geisterfer AAT. Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988;62:749-756.
3. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989;13:305-314.
4. Naftilan AJ, Pratt RE, Eldridge CS, Lin HL, Dzau VJ. Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension 1989;13:706-711.
5. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1419-1424.
6. Zierhut W, Zimmer H.-G. Significance of myocardial α- and β-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 1989;65:1417-1425.
7. Motz W, Klepzig M, Strauer BE. Regression of cardiac hypertrophy: experimental and clinical results. J Cardiovasc Pharmacol 1987;10(suppl 6):S148-S152.
8. Rogers TB. High affinity angiotensin II receptors in myocardial sarcolemmal membranes: characterization of receptors and covalent linkage of 125J-angiotensin II to a membrane component of 116,000 daltons. J Biol Chem 1984;259:8106-8114.
9. Rogers TB, Gaa ST, Allen IS. Identification and characterization of functional angiotensin II receptors on cultured heart myocytes. J Pharmacol Exp Therap 1986;236:438-444.
10. Eichstaedt H, Danne O, Langer M, et al. Regression of left ventricular hypertrophy under ramipril treatment investigated by nuclear magnetic resonance imaging. J Cardiovasc Pharmacol 1989;13(suppl 3):S75-S80.
11. Schölkens BA, Becker RHA, Linz W. Pharmakologische Beeinflussung des Konversionsenzyms-Lokale und systemische Effekte an Herz und Gefässen. Z Kardiol 1988;77(suppl 3):13-21.
12. Hori M, Iwai K, Iwakura K, Sato H, Kitabatake A. Angiotensin II stimulates protein synthesis in neonatal rat cardiomyocytes through enhanced Na+/H+ exchange [Abstract]. Circulation 1989;80(suppl II):II-450.
13. Katoh Y, Komuro I, Shibasaki Y, Yamaguchi H, Yazaki Y. Angiotensin II induces hypertrophy and oncogene expression in cultured rat heart myocytes [Abstract]. Circulation 1989;80(suppl II):II-450.
14. Zimmer H-G, Zierhut W, Seesko RC, Varekamp AE. Right heart catheterization in rats with pulmonary hypertension and right ventricular hypertrophy. Basic Res Cardiol 1989; 83:48-57.
15. Unger T, Ganten D, Lang RE, Schölkens BA. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1985;7:36-41.
16. Glock GE, McLean P. Levels of enzymes of the direct oxidative pathway of carbohydrate metabolism in mammalian tissues and tumors. Biochem J 1954;56:171-175.
17. Bishop SP, Drummond JL. Surface morphology and cell size measurements of isolated rat cardiac myocytes. J Mol Cell Cardiol 1979;11:423-433.
18. Hurley J. Sizing particles with a Coulter counter. Biophvs J 1970;10:74-79.
19. Gerdes AM, Moore JA, Hines JM, Kirkland PA, Bishop SP. Regional differences in myocyte size in normal rat heart. Anat Ree 1986;215:420-426.
20. Zimmer H-G, Gerlach E. Changes of myocardial adenine nucleotide and protein synthesis during development of cardiac hypertrophy. Basic Res Cardiol 1977;72:241-246.
21. Zimmer H-G, Gerlach E. Effect of beta-adrenergic stimulation on myocardial adenine nucleotide metabolism. Circ Res 1974;35:536-543.
22. Zimmer H-G, Ibel H. Gerlach E. Significance of the hexose monophosphate shunt in experimentally induced cardiac hypertrophy. Basic Res Cardiol 1980;75:207-213.
23. Freeman GL, Little WC, Haywood JR. Reduction of left ventricular mass in normal rats by captopril. Cardiovasc Res 1987;21:323-327.
24. Jackson TR, Blair LAC, Marshall J, Goedert M, Hanley MR. The mas oncogene encodes an angiotensin receptor. Nature 1988:335:437-440.
25. Lindpaintner K, Wilhelm MJ, Jin M, et al. Tissue renin-angiotensin systems: focus on the heart. J Hypertens 1987;5(suppl 2):S33-S38.
26. Campbell SE, Gerdes AM. Regional differences in cardiac myocyte dimensions and number in Sprague-Dawley rats from different suppliers. Proc Soc Exp Biol Med 1987;186:211-217.
27. Olivetti G, Ricci R, Lagrasta C, Maniga E, Sonnenblick EH, Anversa P. Cellular basis of wall remodelling in long-term pressure overload-induced right ventricular hypertrophy in rats. Circ Res 1988;63:648-657.
28. Bai S, Campbell SE, Moore JA, Morales MC, Gerdes AM. Influence of age, growth, and sex on cardiac myocyte size and number in rats. Anal Ree 1990;226:207-212.
29. Powell JS, Clozel J-P, Müller RKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188.
30. Campbell-Boswell M, Robertson AL. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 1981;35:265-276.
31. Linz W, Schölkens BA, Han Y-F. Beneficial effects of converting enzyme inhibitor, ramipril, in ischemic rat hearts. J Cardiovasc Pharmacol 1986;8(suppl 10):S91-S99.
32. Schölkens BA, Linz W. Local inhibition of angiotensin II formation and bradykinin degradation in isolated hearts. Clin Exp Hypertens [A] 1988;A10:1259-1270.
33. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987;79:1-6.
34. Owen NE, Villereal ML. Lys-bradykinin stimulates Na+ influx and DNA synthesis in cultured human fibroblasts. Cell 1983;32:979-985.
35. Hudlická O. Growth of capillaries in skeletal and cardiac muscle. Circ Res 1982;50:451-461.
36. Mall G, Schikora I, Mattfeld T, Bodle R. Dipyridamole-induced neoformation of capillaries in the rat heart. Quantitative stereological study on papillary muscles. Lab Invest 1987;57:86-93.